RT @FrontOncology: New research: Case Report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies…
338 followers
1,166 followers
Topic worth thinking about 🧐
867 followers
RT @Dr_Ivanoncologo: MAP2K1 K57N mutation is a mechanism of resistance to anti-EGFR agents in #metastatic #colorectalcancer (mCRC), anti-#E…
3,793 followers
MAP2K1 K57N mutation is a mechanism of resistance to anti-EGFR agents in #metastatic #colorectalcancer (mCRC), anti-#EGFR agents must be omitted in the MAP2K1 K57N mutant mCRC. @fsgcrc @latamccr @VivekSubbiah @PatelOncology https://t.co/GSxrrEumiC https:/